India is set to overhaul its 50-year-old Integrated Child Development Services (ICDS) programme, restructuring child welfare delivery under a new framework. The makeover will target nutrition, early childhood care and development through revised programme design and implementation. #Food #Health

Wockhardt has launched the Antibiotic Academy to combat India’s superbug crisis, aiming to educate doctors on responsible antibiotic use and reduce antimicrobial resistance, which causes nearly 10 lakh deaths annually; the academy promotes evidence-based prescribing, clinician collaboration, and supports new drugs like Zaynich and Miqnaf to ensure effective treatment while preventing misuse. #Health #Medicine

Source

Noccarc, a Pune-based med-tech startup founded by IIT Kanpur alumni, has moved from pandemic-era ventilator manufacturing to building a broader critical-care technology business. With ₹26.5 crore in FY26 revenue and profitability achieved, the company is now targeting further growth while expanding into patient monitors and radiology, as it seeks to challenge established multinational medical-device players.

#health #atmanirbharta
https://youtu.be/i8kZs-_3et8

PopVax is one of India’s most important biotech startups.

They're developing vaccines to fight Hep C, Strep A, TB, influenza, HPV, and malaria, as well as cancer immunotherapies against tumours like liver/pancreatic cancer. Their RNA foundry is in Hyderabad.

#atmanirbharta #health #tech

Recent neuroscience research and meta-analyses show that heavy consumption of short-form videos like TikTok, Instagram Reels, and YouTube Shorts weakens attention span, memory, and cognitive control by overstimulating reward circuits and reducing activity in brain regions responsible for deep focus. #Health

Indian Scientists Create RK-251, A Cancer Drug That Targets Only Cancer Cells 🧬

🔹 Indian scientists develop RK-251, a drug designed to activate only inside cancer cells and spare healthy cells
🔹 How it works: High ROS levels in cancer cells trigger RK-251 to release "NBDHEX", which blocks proteins cancer cells use to survive
🔹 Preclinical results: Strong activity against aggressive triple-negative breast cancer cells, minimal impact on healthy cells
🔹 Zebrafish embryo tests showed no toxicity + fluorescence in presence of ROS, indicating safety potential
🔹 Goal: Replace traditional chemotherapy that damages both cancer + healthy cells

#Health #Medicine

🔗 PIB

India has recorded the second-highest improvement in HDI since 1990 and the latest figures will likely push it above 0.700, into the high human development category.

#health #infrastructure

DRL, Emcure Cleared For Twice-Yearly HIV Prevention Jab Lenacapavir

🔹 CDSCO waives Phase-III & BE trials for prevention use; asks for Phase-IV study in India
🔹 Drug: 463.5mg/1.5ml, twice-yearly injectable, for at-risk adults ≥35kg; approved in US, UK, EU etc
🔹 Prevention waiver only; treatment for MDR-HIV denied over lack of Indian PK data
🔹 Gilead licensed generics to 6 cos for 120 low-income nations; DRL & Emcure first to get nod
#Medicine #Health

The Food Safety and Standards Authority of India (FSSAI) on Friday (August 28, 2026) submitted in the Supreme Court a proposal to provide information relating to added sugar, fat and salt in pictorial form on the front-of-pack (FOP) of food products, in line with international regulations.

Opinion - They should add carcinogens to the proposal as well.

#Health #Policy
https://www.thehindu.com/sci-tech/health/fssai-proposes-front-of-pack-red-pictorial-warnings-for-foods-high-in-fat-sugar-salt/article71402049.ece

🚀 ₹1,600Cr Approved for 41 Pharma & MedTech Projects under PRIP!

The government funding will back 19 startups and 22 large companies (like Biocon & Bharat Biotech), unlocking ₹3,020Cr in private funds to create a ₹4,620Cr total R&D pool. Spanning 27 New Medicines, 9 Medical Devices, and 5 Complex Generics, the portfolio includes breakthrough in-vivo CAR-T platforms, superbug therapeutics, and vaccines for dengue, pneumonia, and TB. #Medicine #Health

Source

FSSAI directs intensified festive surveillance, inspections, and on-the-spot testing to ensure safe, quality, and adulteration-free food during the festive season: FSSAI

#Health

Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins

▶️The government capped trade margins at 30% of MRP for non-scheduled anti-cancer drugs

▶️This price cap applies to branded, generic, domestic, imported, patented, and non-patented drugs

▶️The move could reduce cancer drug prices by up to 70%, saving patients about Rs 2,500 crore yearly

More on - The Times Of India

#health

💊🇧🇪 Mankind Pharma to acquire 70% stake in Belgian biotech Armed Cell Therapeutics (ACTx) for €48M (~₹511 cr) via Netherlands subsidiary — marks entry into next-gen CAR-T cancer therapies. Deal gives access to armed CAR-T platform targeting non-Hodgkin lymphoma & small-cell lung cancer, with in-vivo production tech to tackle relapse & solid tumours. #Medicine #Health

Source

🇮🇳 Centre backs development of an indigenous 32-slice CT scanner.

🤝 TDB signs agreement with Karnataka-based Panacea Medical Technologies.

🏥 Project targets domestic manufacturing of advanced diagnostic imaging equipment.

#health #tech #MakeInIndia

https://swarajyamag.com/tech/india-moves-to-develop-indigenous-32-slice-ct-scanner-as-centre-backs-karnataka-based-medtech-firm

BREAKING: Food regulator FSSAI has initiated legal proceedings for PROSECUTION against Surya Food & Agro Ltd, the maker of Priyagold Biscuits.

An inspection revealed the company was allegedly using bran meant for CATTLE feed as a raw material and fiber source in biscuits, alongside severe HYGIENE violations. #Health

🏗️⚡ L&T has officially won the contract to build India’s first dedicated medical nuclear reactor in Vizag, moving beyond the smaller batch limits of Apsara-U and Dhruva.

📈☢️ The high-flux facility will yield 0.8 MCi/year of specialized radioisotopes by 2031 to power the domestic $1B nuclear medicine market.

📉🏥 This localized production ends reliance on costly foreign imports, drastically lowering the cost of advanced cancer scans and therapies for hospitals. #Nuclear #Health

🚨BILL GATES: The COVID pandemic “didn't work the way I expected.”

“Over the next several years… you will see a lot of ATTACKS different in terms of scale than anything we've seen in the past.”

That literally sounds like a threat…and only validating the "conspiracy theory" of deliberate leak of man-made synthetic virus and corresponding global pandemic and now we are seeing surge of worldwide cyber attacks.

And it's sickening to know that this monster who is responsible for millions of death around the world including India is still walking freely among us.

#health #security

🔥 🎀 CCMB Hyderabad Finds Cell's Viral Switch! 🇮🇳

🔬 A groundbreaking study by Dr. Santosh Chauhan & his team at CSIR-CCMB (Hyderabad) has discovered a dual-action cellular alarm that detects and destroys invading viruses.

🧬 The Discovery: The protein DZIP3 directly grabs onto invading viral RNA, changes its shape, and sounds the alarm.

🔋 Once activated, DZIP3 rushes to the cell's energy hubs (mitochondria) to flag and shield a core immune protein called RIG-I, unleashing a massive wave of protective Type-I interferons.

🛡️ This single molecular switch effectively blocks SARS-CoV-2, Flu, Chikungunya, and Japanese Encephalitis.

💊 Scientists are now searching for small molecules to boost DZIP3, aiming for a single drug that defeats multiple viral threats.#Health

📰 Published in The EMBO Journal (Oct 2026).